Immunobiology of Cancer
NCT00767533 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2016-07-22
Summary
To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
Conditions
- Neoplasms
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Peter P Lee · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy
NCT03333655 ·Status: COMPLETED ·Phase: PHASE4
-
Microarray Analysis of Gene Expression in Liver Tumors
NCT00373737 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Analyzing the Composition of Tears to Identify Cancer
NCT00574678 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
NCT00899704 ·Status: WITHDRAWN
-
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 ·Status: COMPLETED ·Phase: NA
-
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
NCT05683353 ·Status: ACTIVE_NOT_RECRUITING
-
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
NCT00900094 ·Status: COMPLETED
-
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
NCT00610415 ·Status: COMPLETED
-
Clinical and Pathologic Studies in Neuroendocrine Tumors
NCT00657332 ·Status: WITHDRAWN
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
NCT01563874 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Longitudinal Study of Biomarkers
NCT01595126 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Anabolic Response Cancer
NCT02793531 ·Status: WITHDRAWN ·Phase: NA
-
Circulating Fetal Cells and Breast Cancer
NCT04903990 ·Status: UNKNOWN